We are happy to report that an application to establish the NeuroMod+ research network was successfully funded by the EPSRC (£1,265,849).
This research network brings together MedTech businesses, including Neurotherapeutics Ltd, with researchers, clinicians, patients, and medical charities to co-create and develop the next-generation of neuromodulation therapeutics. Neurotherapeutics Ltd will be an active collaborator in this network.
